Skip to main content
user-generated· Science

Will another drug designed to delay the onset of type 1 diabetes be a…

The approval of Teplizumab marks a significant breakthrough. This question gauges the potential for further innovation and regulatory approval of similar preventative treatments within the next few years.

Science · Prediction Market

Implied probability (Yes)
30%
Closes
2027-12-31

More Science markets

Browse all Science markets →

Loading…